Lung deposition of inhaled once-daily long-acting muscarinic antagonists standard jet nebulizer or dry powder inhaler, measured using functional respiratory imaging, in patients w... by Glenn D. Crater, Karmon Johnson, Jonathan Ward, Jan De Backer

Get full text

Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III tri... by Sanjay Sethi, James F. Donohue, Gary T. Ferguson, Chris N. Barnes, Glenn D. Crater

Get full text

Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis by James F. Donohue, Edward Kerwin, Chris N. Barnes, Edmund J. Moran, Brett Haumann, Glenn D. Crater

Get full text

Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow by Jill A. Ohar, Donald A. Mahler, Gabrielle N. Davis, David A. Lombardi, Edmund J. Moran, Glenn D. Crater

Get full text

Safety, tolerability, pharmacodynamics and pharmacokinetics of umeclidinium and vilanterol alone and in combination: a randomized crossover trial. by Dennis L Kelleher, Rashmi S Mehta, Bernadette M Jean-Francois, Andrew F Preece, James Blowers, Glenn D Crater, Paul Thomas

Get full text